CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-09 | Smith Jason Drew General Counsel | Option exercise | +3,333 | 26,747 | ||
| 2024-09-09 | Smith Jason Drew General Counsel | Sale | −1,521 | $13.08 | $20K | 25,226 |
| 2024-09-09 | Smith Jason Drew General Counsel | Option exercise · Restricted Stock Units | −3,333 | 6,667 | ||
| 2024-09-09 | Kim Dong Chief Financial Officer | Option exercise | +2,500 | 37,753 | ||
| 2024-09-09 | Kim Dong Chief Financial Officer | Option exercise · Restricted Stock Units | −2,500 | 5,000 | ||
| 2024-08-06 | Belldegrun Arie Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2024-08-06 | Cohen Fred E Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2024-08-06 | Wildman Daniel George Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2024-08-06 | Holden Stuart Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2024-08-06 | Robinson James A. Jr. Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2024-08-06 | WEN LEANA Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2024-08-06 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2024-06-10 | Schoenberg Mark Chief Medical Officer | Option exercise | +10,000 | 149,437 | ||
| 2024-06-10 | Schoenberg Mark Chief Medical Officer | Sale | −5,153 | $13.08 | $67K | 144,284 |
| 2024-06-10 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −10,000 | 20,000 | ||
| 2024-03-18 | Schoenberg Mark Chief Medical Officer | Sale | −12,000 | $14.05 | $169K | 139,437 |
| 2024-02-01 | Smith Jason Drew General Counsel | Sale | −417 | $15.78 | $7K | 18,824 |
| 2024-02-01 | Smith Jason Drew General Counsel | Sale | −1,248 | $15.78 | $20K | 20,076 |
| 2024-02-01 | Smith Jason Drew General Counsel | Sale | −3,328 | $15.78 | $53K | 23,414 |
| 2024-02-01 | Schoenberg Mark Chief Medical Officer | Sale | −1,137 | $15.78 | $18K | 149,423 |
Page 7 of 13 · 244 trades